Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-035924
Filing Date
2015-04-24
Accepted
2015-04-24 14:06:32
Documents
1
Period of Report
2015-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4028
  Complete submission text file 0001209191-15-035924.txt   5429
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DR SUITE 385 SAN DIEGO CA 92130
Business Address
Brady Todd C (Reporting) CIK: 0001579179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 15791216